Literature DB >> 25257763

Risk factors for cataracts in systemic lupus erythematosus (SLE).

Khaled Alderaan1, Vuk Sekicki, Laurence S Magder, Michelle Petri.   

Abstract

Cataract is the most common ocular damage in systemic lupus erythematosus (SLE). We analyzed data from the Hopkins Lupus Cohort longitudinally to identify the factors that predict onset of cataract prior to 60 years of age. The Hopkins Lupus Cohort is a clinical cohort of patients with SLE seen quarterly. This analysis was based on the follow-up experience prior to age 60 of 2,109 SLE patients who had not had a cataract prior to cohort entry. Patients saw their ophthalmologist every 6 months. Cataract was defined by the SLICC/American College of Rheumatology Damage Index. The rate of incident cataract was calculated in subsets of the follow-up defined by patient characteristics and history. Multivariable logistic regression models were fit to identify predictors of cataract while controlling for potential confounding variables. The analysis was based on 11,887 persons-years of follow-up, with median follow-up time of 4.1 years per patient. The incidence of cataract was 13.2/1,000 persons-years. Adjusting for other predictors, a cumulative prednisone dose equivalent to 10 mg/day for 10 years was a strong predictor of cataract (RR = 2.9, P = 0.0010). Disease activity measured by SELENA-SLEDAI (P = 0.0004) and higher systolic blood pressure (P = 0.0003) were associated with cataract. Duration of SLE, diabetes mellitus, smoking, cholesterol, renal involvement, immunological profile and medication history other than prednisone were not associated with cataract. Cataract development in SLE patients is multifactorial with prednisone, systolic blood pressure and disease activity all playing a role.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25257763     DOI: 10.1007/s00296-014-3129-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  38 in total

1.  Cigarette smoking, body mass index associated with the risks of age-related cataract in male patients in northeast China.

Authors:  Zhi-Quan Lu; Wen-Hui Sun; Jia Yan; Teng-Xuan Jiang; Shu-Na Zhai; Yan Li
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  Long-term prednisone in doses of less than 5 mg/day for treatment of rheumatoid arthritis: personal experience over 25 years.

Authors:  T Pincus; I Castrejón; T Sokka
Journal:  Clin Exp Rheumatol       Date:  2011-10-22       Impact factor: 4.473

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Healthy diets and the subsequent prevalence of nuclear cataract in women.

Authors:  Julie A Mares; Rick Voland; Rachel Adler; Lesley Tinker; Amy E Millen; Suzen M Moeller; Barbara Blodi; Karen M Gehrs; Robert B Wallace; Richard J Chappell; Marian L Neuhouser; Gloria E Sarto
Journal:  Arch Ophthalmol       Date:  2010-06

5.  Ocular changes due to the treatment of juvenile systemic lupus erythematosus.

Authors:  Melissa Mariti Fraga; Claudio Arnaldo Len; Luciana Peixoto dos Santos Finamor; Kimble Teixeira Fonseca Matos; Cristina Muccioli; Maria Odete Esteves Hilário; Maria Teresa Ramos Ascensão Terreri
Journal:  Rev Bras Reumatol       Date:  2011-12

6.  [Ophthalmological alterations in outpatients with systemic lupus erythematosus].

Authors:  Tatiana Klejnberg; Haroldo Vieira de Moraes Junior
Journal:  Arq Bras Oftalmol       Date:  2006-05-08       Impact factor: 0.872

7.  Systemic lupus erythematosus: initial manifestations and clinical features after 10 years of disease.

Authors:  K Y Fong; J Thumboo; E T Koh; H H Chng; K H Leong; W H Koh; H S Howe; K P Leong; B Lim; D R Koh; S C Ng; P H Feng; M L Boey
Journal:  Ann Acad Med Singapore       Date:  1997-05       Impact factor: 2.473

Review 8.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

9.  A prospective study of cigarette smoking and risk of cataract in men.

Authors:  W G Christen; J E Manson; J M Seddon; R J Glynn; J E Buring; B Rosner; C H Hennekens
Journal:  JAMA       Date:  1992-08-26       Impact factor: 56.272

10.  Prevalence of ocular manifestations in systemic sclerosis patients.

Authors:  Arleta Waszczykowska; Roman Goś; Elżbieta Waszczykowska; Bożena Dziankowska-Bartkowiak; Piotr Jurowski
Journal:  Arch Med Sci       Date:  2013-11-29       Impact factor: 3.318

View more
  10 in total

Review 1.  Why targeted therapies are necessary for systemic lupus erythematosus.

Authors:  L Durcan; M Petri
Journal:  Lupus       Date:  2016-09       Impact factor: 2.911

2.  The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years?

Authors:  G Stojan; M Petri
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-07-27

3.  Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort.

Authors:  Michelle Petri; Laurence S Magder
Journal:  Arthritis Rheumatol       Date:  2018-11       Impact factor: 10.995

4.  Is chronic periodontitis premature in systemic lupus erythematosus patients?

Authors:  Débora Cerqueira Calderaro; Gilda Aparecida Ferreira; Jôice Dias Corrêa; Santuza Maria Souza Mendonça; Tarcília Aparecida Silva; Fernando Oliveira Costa; Antônio Lúcio Teixeira
Journal:  Clin Rheumatol       Date:  2016-08-24       Impact factor: 2.980

5.  Association of African-American ethnicity and smoking status with total and individual damage index in systemic lupus erythematosus.

Authors:  Romy Kallas; Jessica Li; Michelle Petri
Journal:  Clin Rheumatol       Date:  2019-11-08       Impact factor: 2.980

Review 6.  Treatment of chronic kidney diseases with histone deacetylase inhibitors.

Authors:  Na Liu; Shougang Zhuang
Journal:  Front Physiol       Date:  2015-04-28       Impact factor: 4.566

7.  Age-Related Cataract Is Associated with Elevated Serum Immunoglobulin E Levels in the South Korean Population: A Cross-Sectional Study.

Authors:  Tae Keun Yoo; Sun Woong Kim; Kyoung Yul Seo
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

8.  Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience.

Authors:  Chiara Tani; Elena Elefante; Viola Signorini; Dina Zucchi; Valentina Lorenzoni; Linda Carli; Chiara Stagnaro; Francesco Ferro; Marta Mosca
Journal:  RMD Open       Date:  2019-06-11

9.  Risks of ophthalmic disorders in patients with systemic lupus erythematosus - a secondary cohort analysis of population-based claims data.

Authors:  Chun-Shuo Hsu; Chia-Wen Hsu; Ming-Chi Lu; Malcolm Koo
Journal:  BMC Ophthalmol       Date:  2020-03-11       Impact factor: 2.209

10.  Prevalence and Spectrum of Eye Disorders Among Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus in a Tertiary Hospital in Northern Nigeria.

Authors:  Maryam H Abdullahi; Victoria Pam; Kehinde Kabir Oladigbolu; Abdul Aziz Umar; Rilwan Chiroma Muhammad
Journal:  J West Afr Coll Surg       Date:  2022-08-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.